COMPASS: The impact of statistical properties of incremental monetary net benefit and incremental cost-effectiveness ratio on health economic modeling choices
Expert Review of Pharmacoeconomics & Outcomes Research
F Yuan, SI Bangdiwala, W Tong, A Lamy
November 2022